Anthera Pharmaceuticals Inc Uncategorized Contracts & Agreements

48 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement between Anthera Pharmaceuticals, Inc. and Craig Thompson, dated June 15, 2018
Anthera Pharmaceuticals Inc
Pharmaceuticals
2018
[remainder of page left blank intentionally.]
Anthera Pharmaceuticals Inc
Pharmaceuticals
2017
Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545
Anthera Pharmaceuticals Inc
Pharmaceuticals
2016
* * * *
Anthera Pharmaceuticals Inc
Pharmaceuticals
2016
Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 July 8, 2015
Anthera Pharmaceuticals Inc
Pharmaceuticals
2015
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE...
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2015
655 MONTGOMERY STREET, SUITE 1190 SAN FRANCISCO, CA 94111-2658
Anthera Pharmaceuticals Inc
Pharmaceuticals
2014
Exhibit No
Anthera Pharmaceuticals Inc
Pharmaceuticals
2011
Exhibit No
Anthera Pharmaceuticals Inc
Pharmaceuticals
2011
Exhibit No
Anthera Pharmaceuticals Inc
Pharmaceuticals
2011
CURRENT ASSETS
Anthera Pharmaceuticals Inc
Pharmaceuticals
2011
convenient, at-home, patient-administered subcutaneous dosing
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
ANTHERA PHARMACEUTICALS, INC.
Anthera Pharmaceuticals Inc
Pharmaceuticals
NY
2010
CURRENT ASSETS
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
DE
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
DE
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2010
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
NY
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
CA
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
DE
2009
advancing A-002 through Phase 3
Anthera Pharmaceuticals Inc
Pharmaceuticals
2009